1. Home
  2. DRI vs BNTX Comparison

DRI vs BNTX Comparison

Compare DRI & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Darden Restaurants Inc.

DRI

Darden Restaurants Inc.

HOLD

Current Price

$214.93

Market Cap

25.9B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$100.30

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRI
BNTX
Founded
1968
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9B
24.2B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
DRI
BNTX
Price
$214.93
$100.30
Analyst Decision
Buy
Strong Buy
Analyst Count
25
13
Target Price
$226.50
$133.46
AVG Volume (30 Days)
802.2K
1.6M
Earning Date
03-19-2026
05-05-2026
Dividend Yield
3.06%
N/A
EPS Growth
17.16
N/A
EPS
10.38
N/A
Revenue
$13,210,900,000.00
N/A
Revenue This Year
$10.58
N/A
Revenue Next Year
$3.73
$3.37
P/E Ratio
$20.65
N/A
Revenue Growth
9.39
N/A
52 Week Low
$169.00
$79.81
52 Week High
$229.76
$124.00

Technical Indicators

Market Signals
Indicator
DRI
BNTX
Relative Strength Index (RSI) 50.05 50.50
Support Level $190.21 $87.58
Resistance Level $220.00 $104.05
Average True Range (ATR) 5.14 3.95
MACD -1.43 -0.44
Stochastic Oscillator 21.37 35.73

Price Performance

Historical Comparison
DRI
BNTX

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest global full-service dining operator, with over $12 billion in system sales across 2,159 company-owned stores at the end of fiscal 2025, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (43% of sales), LongHorn Steakhouse (25%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 154 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: